Asahi Kasei Life Science expects to offer the bioindustry more agile and focused services and deeper innovation in bioprocess solutions.

Asahi Kasei faces challenges from trade tensions and macroeconomic pressures, particularly in its basic materials business. The homes segment shows strong performance with solid backlogs and ...

TOKYO & NOVI, Mich., & DÜSSELDORF, Germany, April 08, 2025--(BUSINESS WIRE)--To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to ...

Leading the way for the sector’s continued growth and commitment to improving patient outcomes Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, as the Leader of ...

Furuya Metal Co., Ltd. and Asahi Kasei Corp. have, in collaboration with Nobian Industrial Chemicals B.V. and Mastermelt Ltd, embarked on a demonstration trial regarding the recycling of metals used ...

Asahi Kasei stock opened at $13.29 on Thursday. Asahi Kasei has a 1-year low of $12.12 and a 1-year high of $15.80. The business has a fifty day moving average price of $13.70 and a 200-day moving ...

Asahi Kasei has a 12-month low of $12.14 and a 12-month high of $15.80. The company has a quick ratio of 0.99, a current ratio of 1.69 and a debt-to-equity ratio of 0.43.

TOKYO -- Japanese homebuilder Asahi Kasei will soon enter the thriving market of Texas and make the operation in the U.S. state a central part of the group's growth strategy, President Koshiro ...

NOVI, Mich. & DÜSSELDORF, Germany & TOKYO, April 24, 2025--(BUSINESS WIRE)--Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, as the Leader of its Healthcare Sector ...